|
miESC 2013: April 25-27

|
| |
|
miESC 2012: January 14-15, SUMMARY
Dear Participants On behalf of the miESC Congress , we would like to thank you for your participation in the first minimally invasive Eye Surgery Congress, held this past week in St. Gallen, Switzerland. |
| |
|
miESC 2012: January 14-15 2012 in St. Gallen, Switzerland
To promote dialogue between eye surgeons developing new processes, users, conventional ophthalmologists, industry (R&D, marketing) and academic research units. |
| |
|
 |
Daniel Mojon, MD, FEBO, EMHSA Switzerland
Professor of Ophthalmology University
of Bern and Airport Eye Center, Airport Medical Center, Zurich Airport |
|
 |
Siegfried Priglinger, MD
Austria
Chairman Department of Ophthalmology, Akh Linz, Austria, Assistant Professor
Ludwig-Maximilians University, Munich, Germany |
|
| |
|
Topics presented on current techniques: |
|
- Surgery of the orbit, eyelid and lacrimal system
- Strabism
- Conjunctivitis
- Glaucoma
- Corneal and refractive surgery
|
- Cataract surgery
- Vitreo-retinal surgery
- Tumors
- Intra-vitreal pharmacotherapy
- Robot-aided surgery
|
| |
|
Welcome Address
miESC: minimally invasive Eye Surgery Congress, St. Gallen, Switzerland
We are delighted to invite your company to the minimally invasive Eye Surgery Congress (miESC), and its pre-congress ophthalmic diagnosis at a glance (od@ag) which will take place in Eastern Switzerland, in St.Gallen on January 13th - 15th, 2012.
A program for surgeons and clinical practitioners
Several highly successful congresses have already been organized at St. Gallen. What is the goal of the minimally invasive Eye Surgery Congress (miESC) to be held on January 14 and 15, 2012? It will enable European physicians to attend an international congress without having to travel too far because of the central location of Switzerland within Europe.
Why will ophthalmology benefit from this minimally invasive eye surgery congress?
This international congress is the first to be intended for practising ophthalmologists, whether they perform eye surgery or not. They will learn about the most recent minimally invasive surgical techniques relevant to their patients. We will discuss what type of minimally invasive surgery is needed for which patient, which patients will benefit more from conventional eye surgery, and which specific complications may occur and how they should be handled. The use of a voting system will ensure that a maximal interaction between speakers and attendees will be achieved.
We will also present the latest news of the industry in this field.
The congress also aims to establish a permanent platform to promote minimally invasive eye surgery. Eye surgeons, universities, and ophthalmic firms will regularly exchange innovative ideas to advance more quickly minimally invasive surgery.
In which fields has minimally invasive eye surgery made the greatest progress?
We now have coaxial micro-incision cataract surgery (CoMICS), allowing smaller incisions and femto second cataract surgery, permitting to perform several surgical steps in a still closed eye. Nowadays, in some corneal pathologies, only the endothelium is transplanted. The effect is not as long-lasting as that of perforating keratoplasty, but the process is much less invasive and patients recover much quicker. Perforating keratoplasty may then be performed at a later date. For many vitreoretinal surgical procedures a transconjunctival, suturless access is now standard practice. Minimally invasive strabismus surgery enables us to make highly complex revisions using micro-incisions with no trauma to the cornea and rendering the currently used open surgery quite obsolete.
Prof Daniel Mojon, MD FEBO EMHSA PD |
PD Siegfried Priglinger, MD FEBO |
St. Gallen - Switzerland |
Linz - Austria |
|
|